Skip to main content
. 2005 Nov 23;5(Spec No A):S149–S156. doi: 10.1102/1470-7330.2005.0035

Figure 5.

Figure 5

Comparison of mangafodipir (Teslascan®)-enhanced MRI and CT. (A) Unenhanced T1-weighted MRI shows some lesions in the liver (arrows). (B) There is much better delineation of the metastases on the mangafodipir-enhanced images. (C) On the contrast-enhanced MDCT, only one metastasis in the left lobe is seen. The other lesions were also not seen on adjacent slices.